Literature DB >> 2487157

Consistent occurrence of a 19p+ marker chromosome and loss of 11p material in ovarian seropapillary cystadenocarcinomas.

T Pejovic1, S Heim, N Mandahl, B Elmfors, U M Flodérus, S Furgyik, G Helm, H Willén, F Mitelman.   

Abstract

Cytogenetic analysis of short-term cultures from 11 moderately to poorly differentiated ovarian seropapillary cystadenocarcinomas revealed clonal chromosomal abnormalities in nine tumors. Two bands were involved in structural rearrangements in more than half of the tumors. The band most frequently affected was 19p13; rearrangements giving rise to a 19p+ marker chromosome were found in seven tumors, and in four of them the 19p+ markers appeared to be identical. Structural rearrangements resulting in loss of 11p13-11pter material were found in six tumors.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2487157     DOI: 10.1002/gcc.2870010210

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  9 in total

1.  Interphase molecular cytogenetic analysis of epithelial ovarian carcinomas.

Authors:  D L Persons; L C Hartmann; J F Herath; T J Borell; W A Cliby; G L Keeney; R B Jenkins
Journal:  Am J Pathol       Date:  1993-03       Impact factor: 4.307

2.  Involvement of chromosome 6 in endometrial cancer.

Authors:  M G Tibiletti; B Bernasconi; M Taborelli; D Furlan; A Fabbri; M Franchi; R Taramelli; M Trubia; C Capella
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

Review 3.  The genetic analysis of ovarian cancer.

Authors:  A N Shelling; I E Cooke; T S Ganesan
Journal:  Br J Cancer       Date:  1995-09       Impact factor: 7.640

4.  Bilateral ovarian carcinomas differ in the expression of metastasis-related genes.

Authors:  Marianne Lislerud Smebye; Lisbeth Haugom; Ben Davidson; Claes Göran Trope; Sverre Heim; Rolf Inge Skotheim; Francesca Micci
Journal:  Oncol Lett       Date:  2016-11-14       Impact factor: 2.967

5.  Tumor spreading to the contralateral ovary in bilateral ovarian carcinoma is a late event in clonal evolution.

Authors:  Francesca Micci; Lisbeth Haugom; Terje Ahlquist; Vera M Abeler; Claes G Trope; Ragnhild A Lothe; Sverre Heim
Journal:  J Oncol       Date:  2009-09-15       Impact factor: 4.375

6.  Polymerase chain reaction allelotyping of human ovarian cancer.

Authors:  R J Osborne; V Leech
Journal:  Br J Cancer       Date:  1994-03       Impact factor: 7.640

7.  Loss of heterozygosity and amplification on chromosome 11q in human ovarian cancer.

Authors:  W D Foulkes; I G Campbell; G W Stamp; J Trowsdale
Journal:  Br J Cancer       Date:  1993-02       Impact factor: 7.640

8.  Prognostic impact of chromosome aberrations in ovarian cancer.

Authors:  T Pejovic; A Himmelmann; S Heim; N Mandahl; U M Flodérus; S Furgyik; B Elmfors; G Helm; H Willén; F Mitelman
Journal:  Br J Cancer       Date:  1992-02       Impact factor: 7.640

9.  Involvement of DPP9 in gene fusions in serous ovarian carcinoma.

Authors:  Marianne Lislerud Smebye; Antonio Agostini; Bjarne Johannessen; Jim Thorsen; Ben Davidson; Claes Göran Tropé; Sverre Heim; Rolf Inge Skotheim; Francesca Micci
Journal:  BMC Cancer       Date:  2017-09-11       Impact factor: 4.430

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.